{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:05:24Z","timestamp":1788336324136,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["No.cstc2020jcyj-msxmX0113"],"award-info":[{"award-number":["No.cstc2020jcyj-msxmX0113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Salidroside has anti-inflammatory, antioxidant and hepatoprotective properties. However, its effect on hepatic ischemia\u2013reperfusion injury (IRI), an unavoidable side effect associated with liver transplantation, remains undefined. Here, we aimed to determine whether salidroside alleviates hepatic IRI and elucidate its potential mechanisms. We used both in vivo and in vitro assays to assess the effect and mechanisms of salidroside on hepatic IRI. Hepatic IRI rat models were pretreated with salidroside (5, 10 or 20\u00a0mg\/kg\/day) for 7\u00a0days following liver transplantation while hypoxia\/reoxygenation (H\/R) model of RAW 264.7 macrophages were pretreated with salidroside (1, 10 or 50\u00a0\u03bcM). The effect of salidroside on hepatic IRI was assessed using hematoxylin\u2013eosin staining, terminal deoxynucleotidyl transferase dUTP nick-end labeling staining, qRT-PCR, immunosorbent assay and western blotting. Our in vivo assays showed that salidroside significantly reduced pathological liver damage, serum aminotransferase levels and serum levels of IL-1, IL-18 and TNF-\u03b1. Besides, salidroside reduced the expression of TLR-4\/NF-\u03baB\/NLRP3 inflammatory pathway associated proteins (TLR-4, MyD88, p-IKK\u03b1, p-IKK\u03b2, p-IKK, p-I\u03baB\u03b1, p-P65, NLRP3, ASC, Cleaved caspase-1, IL-1\u03b2, IL-18, TNF-\u03b1 and IL-6) in rats after liver transplantation. On the other hand, data from the in vitro analysis demonstrated that salidroside blocks expression of TLR-4\/NF-\u03baB\/NLRP3 inflammatory pathway related proteins in the RAW264.7 cells treated with H\/R. The salidroside-specific anti-inflammatory effects were partially inhibited by the TLR-4 agonist lipopolysaccharide. Taken together, our study showed that salidroside inhibits hepatic IRI following liver transplantation by modulating the TLR-4\/NF-\u03baB\/NLRP3 inflammatory pathway.<\/jats:p>","DOI":"10.1038\/s41598-022-18369-4","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T13:03:39Z","timestamp":1660741419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Salidroside alleviates hepatic ischemia\u2013reperfusion injury during liver transplant in rat through regulating TLR-4\/NF-\u03baB\/NLRP3 inflammatory pathway"],"prefix":"10.1038","volume":"12","author":[{"given":"Yanyao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"issue":"4","key":"18369_CR1","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1016\/j.jhep.2019.05.029","volume":"71","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. J. Hepatol. 71(4), 7199\u20137730 (2019).","journal-title":"J. Hepatol."},{"issue":"6","key":"18369_CR2","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/hep.23595","volume":"51","author":"TE Starzl","year":"2010","unstructured":"Starzl, T. E. & Fung, J. J. Themes of liver transplantation. Hepatol. 51(6), 1869\u20131884 (2010).","journal-title":"Hepatol."},{"key":"18369_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/hep.30203","volume":"69","author":"L Yang","year":"2019","unstructured":"Yang, L. et al. Creg in hepatocytes ameliorates liver ischemia\/reperfusion injury in a TAK1-dependent manner in mice. Hepatology 69, 294\u2013313 (2019).","journal-title":"Hepatology"},{"key":"18369_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/SLA.0000000000003085","volume":"271","author":"RA Sosa","year":"2020","unstructured":"Sosa, R. A. et al. Pattern recognition receptor-reactivity screening of liver transplant patients: potential for personalized and precise organ matching to reduce risks of ischemia-reperfusion injury. Ann. Surg. 271, 922\u2013931 (2020).","journal-title":"Ann. Surg."},{"issue":"3","key":"18369_CR5","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e24","volume":"18","author":"T Lu","year":"2018","unstructured":"Lu, T. et al. Dual effect of hepatic macrophages on liver ischemia and reperfusion injury during liver transplantation. Immune Netw. 18(3), e24 (2018).","journal-title":"Immune Netw."},{"issue":"6","key":"18369_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2174\/1871527315666160321111829","volume":"15","author":"Z Guo","year":"2016","unstructured":"Guo, Z. et al. NLRP3 is involved in ischemia\/reperfusion injury. CNS Neurol. Disord. Drug Targets. 15(6), 699\u2013712 (2016).","journal-title":"CNS Neurol. Disord. Drug Targets."},{"key":"18369_CR7","first-page":"272","volume":"19","author":"L Liu","year":"2015","unstructured":"Liu, L. et al. Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction. J. Cell. Mol. Med. 19, 272\u2013340 (2015).","journal-title":"J. Cell. Mol. Med."},{"issue":"11","key":"18369_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.544124","volume":"8","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. Aucubin attenuates liver ischemia-reperfusion injury by inhibiting the HMGB1\/TLR-4\/NF-\u03baB signaling pathway, oxidative stress, and apoptosis. Front. Pharmacol. 8(11), 544124 (2020).","journal-title":"Front. Pharmacol."},{"issue":"2019","key":"18369_CR9","first-page":"5637235","volume":"20","author":"T Gong","year":"2019","unstructured":"Gong, T. et al. Dibromoacetic acid induced hepatotoxicity in mice through oxidative stress and toll-like receptor 4 signaling pathway activation. Oxid. Med. Cell Longev. 20(2019), 5637235 (2019).","journal-title":"Oxid. Med. Cell Longev."},{"issue":"12","key":"18369_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.646307","volume":"16","author":"L Xu","year":"2021","unstructured":"Xu, L. et al. viaSevoflurane postconditioning attenuates hepatic ischemia-reperfusion injury by limiting HMGB1\/TLR4\/NF-\u039ab pathway modulating microRNA-142. Front. Pharmacol. 16(12), 646307 (2021).","journal-title":"Front. Pharmacol."},{"key":"18369_CR11","doi-asserted-by":"publisher","first-page":"115340","DOI":"10.1016\/j.taap.2020.115340","volume":"410","author":"A El-Sisi","year":"2021","unstructured":"El-Sisi, A. et al. Octreotide and melatonin alleviate inflammasome-induced pyroptosis through inhibition of TLR4-NF-\u03baB-NLRP3 pathway in hepatic ischemia\/reperfusion injury. Toxicol. Appl. Pharmacol. 410, 115340 (2021).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"9","key":"18369_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.it.2021.07.005","volume":"42","author":"J Liang","year":"2021","unstructured":"Liang, J., Fraser, I. & Bryant, C. Lipid regulation of NLRP3 inflammasome activity through organelle stress. Trends Immunol. 42(9), 807\u2013823 (2021).","journal-title":"Trends Immunol."},{"issue":"9","key":"18369_CR13","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11909","volume":"10","author":"Y Pan","year":"2021","unstructured":"Pan, Y. et al. N-acetyl-L-tryptophan attenuates hepatic ischemia-reperfusion injury via regulating TLR4\/NLRP3 signaling pathway in rats. PeerJ 10(9), e11909 (2021).","journal-title":"PeerJ"},{"issue":"12","key":"18369_CR14","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.2147\/DDDT.S160776","volume":"24","author":"Z Zhong","year":"2018","unstructured":"Zhong, Z. et al. Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system. Drug Des. Devel. Ther. 24(12), 1479\u20131489 (2018).","journal-title":"Drug Des. Devel. Ther."},{"issue":"7","key":"18369_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202100033","volume":"18","author":"C Zhao","year":"2021","unstructured":"Zhao, C. et al. The therapeutic effects and mechanisms of salidroside on cardiovascular and metabolic diseases: An updated review. Chem. Biodivers. 18(7), e2100033 (2021).","journal-title":"Chem. Biodivers."},{"key":"18369_CR16","doi-asserted-by":"publisher","first-page":"109268","DOI":"10.1016\/j.cbi.2020.109268","volume":"339","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties. Chem. Biol. Interact. 339, 109268 (2021).","journal-title":"Chem. Biol. Interact."},{"issue":"2020","key":"18369_CR17","doi-asserted-by":"crossref","first-page":"9568647","DOI":"10.1155\/2020\/9568647","volume":"26","author":"S Sun","year":"2020","unstructured":"Sun, S. et al. Antioxidant effects of salidroside in the cardiovascular system. Evid. Based Complement Altern. Med. 26(2020), 9568647 (2020).","journal-title":"Evid. Based Complement Altern. Med."},{"key":"18369_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.152905","volume":"461","author":"Y Yuan","year":"2021","unstructured":"Yuan, Y. et al. Salidroside alleviates liver inflammation in furan-induced mice by regulating oxidative stress and endoplasmic reticulum stress. Toxicology 461, 152905 (2021).","journal-title":"Toxicology"},{"key":"18369_CR19","first-page":"56933","volume":"133","author":"L Yang","year":"2018","unstructured":"Yang, L. et al. A rat model of orthotopic liver transplantation using a novel magnetic anastomosis technique for suprahepatic vena cava reconstruction. J. Vis. Exp. 133, 56933 (2018).","journal-title":"J. Vis. Exp."},{"issue":"5","key":"18369_CR20","first-page":"717","volume":"108","author":"S Kawasaki","year":"2011","unstructured":"Kawasaki, S. & Ishizaki, Y. Current status and future of cadaveric liver transplantation. Nihon Shokakibyo Gakkai Zasshi. 108(5), 717\u2013722 (2011).","journal-title":"Nihon Shokakibyo Gakkai Zasshi."},{"key":"18369_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/ajt.16219","volume":"21","author":"T Ito","year":"2021","unstructured":"Ito, T. et al. Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients. Am. J. Transpl. 21, 614\u2013625 (2021).","journal-title":"Am. J. Transpl."},{"key":"18369_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jhep.2015.08.021","volume":"64","author":"J Hu","year":"2016","unstructured":"Hu, J. et al. Targeting TRAF3 signaling protects against hepatic ischemia\/reperfusions injury. J. Hepatol. 64, 146\u2013159 (2016).","journal-title":"J. Hepatol."},{"key":"18369_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110458","volume":"129","author":"F Fan","year":"2020","unstructured":"Fan, F. et al. Salidroside as a potential neuroprotective agent for ischemic stroke: A review of sources, pharmacokinetics, mechanism and safety. Biomed. Pharmacother. 129, 110458 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"18369_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00011-012-0545-4","volume":"62","author":"D Li","year":"2013","unstructured":"Li, D. et al. Salidroside attenuates inflammatory responses by suppressing nuclear factor-kappaB and mitogen activated protein kinases activation in lipopolysaccharide-induced mastitis in mice. Inflamm. Res. 62, 9\u201315 (2013).","journal-title":"Inflamm. Res."},{"key":"18369_CR25","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.2147\/DDDT.S162950","volume":"12","author":"J Feng","year":"2018","unstructured":"Feng, J. et al. Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-kappaB and TGF-beta1\/Smad3 pathways. Drug Des. Dev. Ther. 12, 1837\u20131853 (2018).","journal-title":"Drug Des. Dev. Ther."},{"issue":"14","key":"18369_CR26","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2147\/DDDT.S242862","volume":"14","author":"H Gao","year":"2020","unstructured":"Gao, H. et al. Salidroside alleviates cartilage degeneration through NF-\u03baB pathway in osteoarthritis rats. Drug Des. Devel. Ther. 14(14), 1445\u20131454 (2020).","journal-title":"Drug Des. Devel. Ther."},{"issue":"2018","key":"18369_CR27","doi-asserted-by":"crossref","first-page":"8597897","DOI":"10.1155\/2018\/8597897","volume":"22","author":"T Zheng","year":"2018","unstructured":"Zheng, T. et al. Salidroside attenuates high-fat diet-induced nonalcoholic fatty liver disease via AMPK-dependent TXNIP\/NLRP3 pathway. Oxid. Med. Cell Longev. 22(2018), 8597897 (2018).","journal-title":"Oxid. Med. Cell Longev."},{"key":"18369_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129788","volume":"10","author":"H Zou","year":"2015","unstructured":"Zou, H. et al. Salidroside protects against cadmium-induced hepatotoxicity in rats via GJIC and MAPK pathways. PLoS ONE 10, e0129788 (2015).","journal-title":"PLoS ONE"},{"issue":"4","key":"18369_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/cmi.2014.23","volume":"11","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Prognoses of patients with acute-on-chronic hepatitis B liver failure are closely associated with altered SOCS1 mRNA expression and cytokine production following glucocorticoid treatment. Cell. Mol. Immunol. 11(4), 396\u2013404 (2014).","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"18369_CR30","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.3390\/md13063368","volume":"13","author":"J Li","year":"2015","unstructured":"Li, J. et al. Astaxanthin pretreatment attenuates hepatic ischemia reperfusion-induced apoptosis and autophagy via the ROS\/MAPK pathway in mice. Mar. Drugs. 13(6), 3368\u20133387 (2015).","journal-title":"Mar. Drugs."},{"issue":"2","key":"18369_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5114\/aoms.2016.60650","volume":"13","author":"M Kim","year":"2017","unstructured":"Kim, M. et al. The vitamin D analogue paricalcitol attenuates hepatic ischemia\/reperfusion injury through down-regulation of Toll-like receptor 4 signaling in rats. Arch. Med. Sci. 13(2), 459\u2013469 (2017).","journal-title":"Arch. Med. Sci."},{"key":"18369_CR32","doi-asserted-by":"publisher","first-page":"106987","DOI":"10.1016\/j.intimp.2020.106987","volume":"89","author":"L Yang","year":"2020","unstructured":"Yang, L. et al. Inhibition of HMGB1 involved in the protective of salidroside on liver injury in diabetes mice. Int. Immunopharmacol. 89, 106987 (2020).","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"18369_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/cei.13510","volume":"203","author":"H Luo","year":"2021","unstructured":"Luo, H. et al. Mycoplasma pneumoniae lipids license TLR-4 for activation of NLRP3 inflammasome and autophagy to evoke a proinflammatory response. Clin. Exp. Immunol. 203(1), 66\u201379 (2021).","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"18369_CR34","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/bph.13786","volume":"174","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. The TIR\/BB-loop mimetic AS-1 prevents non-alcoholic steatohepatitis and hepatic insulin resistance by inhibiting NLRP3-ASC inflammasome activation. Br. J. Pharmacol. 174(12), 1841\u20131856 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"18369_CR35","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.biopha.2017.03.022","volume":"89","author":"X Li","year":"2017","unstructured":"Li, X. et al. Pre-conditioning with tanshinone IIA attenuates the ischemia\/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells. Biomed. Pharmacother. 89, 1392\u20131400 (2017).","journal-title":"Biomed. Pharmacother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18369-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18369-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18369-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T22:51:02Z","timestamp":1727823062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18369-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18369"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18369-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"assertion":[{"value":"2 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13973"}}